A prospective cohort study of patient-reported vomiting, retching, nausea and antiemetic use during neoadjuvant long-course radiation therapy and concurrent 5-fluorouracil-based chemotherapy for rectal adenocarcinoma

BACKGROUND AND PURPOSE: Antiemetic guidelines suggest daily prophylaxis with a serotonin(3) receptor antagonist (5-HT(3)RA) as an option for patients receiving long-course neoadjuvant radiation therapy and concurrent 5-fluorouracil-based chemotherapy for rectal cancer, despite the risks that 5-HT(3)...

Descripción completa

Detalles Bibliográficos
Autores principales: Dennis, Kristopher, Zeng, Liang, De Angelis, Carlo, Chung, Hans, Coburn, Natalie, Chow, Edward, Wong, C. Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909027/
https://www.ncbi.nlm.nih.gov/pubmed/29682620
http://dx.doi.org/10.1016/j.ctro.2018.04.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5909027/
https://www.ncbi.nlm.nih.gov/pubmed/29682620
http://dx.doi.org/10.1016/j.ctro.2018.04.001

Ejemplares similares